Business Description
Raia Drogasil SA
ISIN : US7507231089
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.19 | |||||
Debt-to-EBITDA | 2.24 | |||||
Interest Coverage | 2.94 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.03 | |||||
Beneish M-Score | -2.13 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.8 | |||||
3-Year EBITDA Growth Rate | 10.1 | |||||
3-Year EPS without NRI Growth Rate | 22.1 | |||||
3-Year Book Growth Rate | 11 | |||||
Future 3-5Y EPS without NRI Growth Rate | 26.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 15.03 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.71 | |||||
9-Day RSI | 38.88 | |||||
14-Day RSI | 41.16 | |||||
6-1 Month Momentum % | 10.89 | |||||
12-1 Month Momentum % | 1.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 0.54 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 103.41 | |||||
Days Sales Outstanding | 27.89 | |||||
Days Payable | 71.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.81 | |||||
Dividend Payout Ratio | 0.59 | |||||
3-Year Dividend Growth Rate | 35 | |||||
Forward Dividend Yield % | 0.81 | |||||
5-Year Yield-on-Cost % | 2.4 | |||||
Shareholder Yield % | -0.61 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.05 | |||||
Operating Margin % | 5.73 | |||||
Net Margin % | 3.11 | |||||
FCF Margin % | -1.04 | |||||
ROE % | 18.83 | |||||
ROA % | 5.69 | |||||
ROIC % | 13.35 | |||||
ROC (Joel Greenblatt) % | 19.11 | |||||
ROCE % | 16.79 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 40.16 | |||||
Forward PE Ratio | 32.79 | |||||
PE Ratio without NRI | 47.43 | |||||
Shiller PE Ratio | 51.01 | |||||
PEG Ratio | 2.87 | |||||
PS Ratio | 1.25 | |||||
PB Ratio | 7.17 | |||||
Price-to-Tangible-Book | 10.64 | |||||
Price-to-Operating-Cash-Flow | 43.99 | |||||
EV-to-EBIT | 26.27 | |||||
EV-to-Forward-EBIT | 21.03 | |||||
EV-to-EBITDA | 15.61 | |||||
EV-to-Forward-EBITDA | 15.21 | |||||
EV-to-Revenue | 1.45 | |||||
EV-to-Forward-Revenue | 1.26 | |||||
EV-to-FCF | -144.31 | |||||
Price-to-Projected-FCF | 5.43 | |||||
Price-to-DCF (Earnings Based) | 1.53 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.27 | |||||
Price-to-Graham-Number | 4.72 | |||||
Earnings Yield (Greenblatt) % | 3.81 | |||||
FCF Yield % | -0.8 | |||||
Forward Rate of Return (Yacktman) % | 20.62 |